Fusion of Technologies Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan.

The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies